GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Boan Biotechnology Co Ltd (FRA:UJ9) » Definitions » Total Assets

Shandong Boan Biotechnology Co (FRA:UJ9) Total Assets : €298.39 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Shandong Boan Biotechnology Co Total Assets?

Shandong Boan Biotechnology Co's Total Assets for the quarter that ended in Dec. 2023 was €298.39 Mil.

During the past 12 months, Shandong Boan Biotechnology Co's average Total Assets Growth Rate was 5.50% per year. During the past 3 years, the average Total Assets Growth Rate was 29.40% per year.

During the past 4 years, Shandong Boan Biotechnology Co's highest 3-Year average Total Assets Growth Rate was 29.40%. The lowest was 29.40%. And the median was 29.40%.

Total Assets is connected with ROA %. Shandong Boan Biotechnology Co's annualized ROA % for the quarter that ended in Dec. 2023 was 0.01%. Total Assets is also linked to Revenue through Asset Turnover. Shandong Boan Biotechnology Co's Asset Turnover for the quarter that ended in Dec. 2023 was 0.16.

Shandong Boan Biotechnology Co Total Assets Historical Data

The historical data trend for Shandong Boan Biotechnology Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Boan Biotechnology Co Total Assets Chart

Shandong Boan Biotechnology Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Assets
114.14 292.71 298.24 298.39

Shandong Boan Biotechnology Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Assets Get a 7-Day Free Trial 286.18 298.24 276.22 298.39 -

Shandong Boan Biotechnology Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Shandong Boan Biotechnology Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=169.508+128.88
=298.39

Shandong Boan Biotechnology Co's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (Q: Dec. 2023 )+Total Liabilities (Q: Dec. 2023 )
=169.508+128.88
=298.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Boan Biotechnology Co  (FRA:UJ9) Total Assets Explanation

Total Assets is connected with ROA %.

Shandong Boan Biotechnology Co's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=0.034/( (276.224+298.387)/ 2 )
=0.034/287.3055
=0.01 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Shandong Boan Biotechnology Co's Asset Turnover for the quarter that ended in Dec. 2023 is

Asset Turnover
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=45.835/( (276.224+298.387)/ 2 )
=45.835/287.3055
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Shandong Boan Biotechnology Co Total Assets Related Terms

Thank you for viewing the detailed overview of Shandong Boan Biotechnology Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Boan Biotechnology Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Boan Biotechnology Co Ltd (FRA:UJ9) » Definitions » Total Assets
Comparable Companies
HKSE:02315 HKSE:02105 HKSE:06855 HKSE:02696 HKSE:02480 HKSE:00775 HKSE:02157 HKSE:01952 HKSE:02171 HKSE:02487 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
06955:Hong Kong
Address
No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN
Website
https://www.boan-bio.com
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.

Shandong Boan Biotechnology Co Headlines

No Headlines